Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2026.

Date: 31st October, 2026 BSE Limited, Department of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street- Fort, Mumbai – 400 001. Scrip Code: 539730 Subject: Prior Intimation for the Board Meeting of the Company to be held on Thursday, 05th November, 2026 Pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, notice is hereby given that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Thursday, 05th November, 2026 inter alia, to consider and approve the following: 1. To discuss, consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2026. 2. Any other matter with the permission of the Chair. Further, in continuation of our intimation dated September 28, 2026 and pursuant to Company's “Code of Conduct” formed under the Securities and Exchange Board of India (Prohibition of Insider Trading”) Regulations, 2015 and amendments thereunder, the trading window for dealing in the securities of the Company has been closed from October 01, 2026 and it shall remain closed until forty-eight hours after the date of declaration of results for the Quarter and Half Year ended September 30, 2026. The same has been circulated to the Directors, Key Managerial Personnel, Employees of the Company and their immediate relatives. Kindly take the same on your records. Thanking you, FOR FREDUN PHARMACEUTICALS LIMITED FREDUN NARIMAN MEDHORA MANAGING DIRECTOR DIN: 01745348